Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial)

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies

(2018) Josep M Llibre et al.   LANCET

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

(2018) Michael S. Saag et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Genital HIV-1 Shedding With Dolutegravir (DTG) Plus Lamivudine (3TC) Dual Therapy

(2018) Sara Gianella et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)

(2018) Véronique Joly et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

(2018) Pedro Cahn et al.   LANCET

Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial

(2017) Pierre de Truchis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

(2017) David A Margolis et al.   LANCET

U=U taking off in 2017

(2017) The Lancet HIV   Lancet HIV

Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications

(2016) Véronique Avettand-Fènoël et al.   CLINICAL MICROBIOLOGY REVIEWS

HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral Regimen

(2016) Arkaitz Imaz et al.   JOURNAL OF INFECTIOUS DISEASES

HIV-1 DNA Levels in Peripheral Blood Mononuclear Cells and Cannabis Use are Associated With Intermittent HIV Shedding in Semen of Men Who Have Sex With Men on Successful Antiretroviral Regimens

(2014) J. Ghosn et al.   CLINICAL INFECTIOUS DISEASES

Characterization of Binding of Raltegravir to Plasma Proteins

(2013) Caroline Barau et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Shedding of HIV and Human Herpesviruses in the Semen of Effectively Treated HIV-1–Infected Men Who Have Sex With Men

(2013) Sara Gianella et al.   CLINICAL INFECTIOUS DISEASES

Etravirine in CSF is highly protein bound

(2013) A. Nguyen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men

(2012) Joseph A. Politch et al.   AIDS

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002–2011 survey

(2012) Sidonie Lambert-Niclot et al.   AIDS

Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma

(2009) Anne-Geneviève Marcelin et al.   AIDS

Persistent HIV RNA shedding in semen despite effective antiretroviral therapy

(2009) Prameet M Sheth et al.   AIDS

Differential Extracellular and Intracellular Concentrations of Zidovudine and Lamivudine in Semen and Plasma of HIV-1-Infected Men

(2008) Julie B Dumond et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES